| Item number | Description | Compatibility | Units per box |
|---|---|---|---|
| BZ4212 | BiZact™ tonsillectomy device | Valleylab™ FT10 energy platform, Valleylab™ LS10 generator | 6 |
Open tonsillectomy devices
BiZact™ tonsillectomy device
<p>The BiZact™ device is a bipolar tissue sealer and divider that is designed to solve the problems of tonsillectomy.</p>
Features
Outperforms other tonsillectomy technologies
From a fast and easy setup∆,7,8 to reliable seals,§,◊,¶ ,3-5 BiZact,™ when compared to published literature on the rate of postoperative bleeding in tonsillectomy using electrosurgery, the Coblator™* instrument, and a cold knife, reduces bleeding after surgery.§,◊,¶ ,3-5
Low energy level. High clinical value.
The BiZact™ device is an advanced bipolar tissue sealer and divider. It’s powered by Valleylab™ energy platforms that:
- Measure impedance of clamped tissue9
- Adjust energy output to create a reliable seal§,◊,¶ ,3-5,9
- Automatically stop energy delivery when the seal is complete9
As a result of this technology, the BiZact™ device:
- Offers fast and easy setup∆,7,8
- Produces seals that withstand three times normal systolic blood pressure10
- Reduces bleeding after surgery§,◊,¶ ,3-5
- Improves procedural efficiency†,‡,1,2,
- Minimal thermal spread5
Clinically proven benefits for your pediatric patients
Reliable:
- Produces seals that withstand 3× normal systolic blood pressure10
Efficient:
- Offers fast and easy setup∆,7,8
- Allows you to finish a case in as little as five minutes11
Fewer complications:
- Reduces bleeding during and after surgery§,◊,¶ ,3-5
- Delivers minimal thermal spread, on average <1 mm12
Ordering information
Related products
Similar products
† Compared to cold steel, the BiZact™ device reduces operative time.
‡ Compared to electrosurgery, the BiZact™ device reduces operative time.
§ Postoperative bleeding rate was 7.0% for BiZact™ patients and 22.4% for cold steel patients.
◊ Postoperative bleeding rate was 7.0% for BiZact™ patients and 17.3% for electrosurgery patients.
¶ Postoperative bleeding rate was 7.0% for BiZact™ patients and 15.6% for coblator patients.
# The BiZact™ device has been shown to produce <1mm thermal spread.
∆ 12 out of 12 surgeons and 13 out of 15 nurses surveyed agreed.
- Falz H, von Lücken HJ, Münscher A, Möckelmann N. A comparative study of BiZact™ tonsillectomy versus cold steel dissection technique in adults: Analysis of operating time, intraoperative blood loss, postoperative bleeding rate and pain. Clin Otolaryngol. 2024;49(3):299–305.
- Manhein, D., and J. Raeder. "Comparison of Bizact™ Low temperature dissecting device with bipolar diathermic scissors for tonsillectomy in adult patients. Austin." J. Surg 10 (2023): 1300.
- Saleem M, Alamgir A, Ali SJ, Hyder HS, Bibi S, Tabassum S. Conventional Cold steel and Modern technique BiZact LigaSure for tonsillectomy: A comparative analysis. Journal of Rawalpindi Medical College. 2022;26(2):253–256.
- BiZact™ tonsillectomy device clinical claims substantiation (v1.0) statistical analysis of 10 publications published between 2018–2024, and 4 publications for cold steel tonsillectomy published between 2021–2024. Data on file, RE00172883.
- BiZact™ tonsillectomy device clinical claims substantiation (v1.0) statistical analysis of 10 publications published between 2018–2024, and 4 publications for cold steel tonsillectomy published between 2018–2023. Data on file, RE00172883.
- BiZact™ tonsillectomy device clinical claims substantiation (v1.0) statistical analysis of 10 publications published between 2018–2024, and 5 publications for cold steel tonsillectomy published between 2018–2021. Data on file, RE00172883.
- Based on internal test report RE00079704, independent surgeon and nurse feedback collected during Medtronic-sponsored labs. January–February 2017
- Based on internal test report RE00073873, independent surgeon and nurse feedback collected during Medtronic-sponsored labs. January–February 2017.
- Based on internal test report RE00077022, porcine testing. January 9–10, 2017.
- Based on internal test report RE00256209, a memo control system resolution.
- Krishnan G, Stepan L, Du C, Padhye V, Bassiouni A, Dharmawardana N, Ooi EH, Krishnan S. Tonsillectomy using the BiZact™: A pilot study in 186 children and adults. Clin Otolaryngol. 2019;44(3):392–396.
- Based on internal test report RE00015788, tissue testing. March 23, 2017.